Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT04891835
Eligibility Criteria:
Inclusion Criteria:
* Patients\> 50 years old diagnosed with neovascular age related macular degeneration,
* Patients who have never received anti-VEGF treatment,
* Patients who started intra-vitreous injections of aflibercept between 01 January 2014 and November 30, 2019,
* Treatment by "treat-and-extend" directly after the loading dose of aflibercept,
* Availability of the medical file reporting treatment with aflibercept.
Exclusion Criteria:
* Participation in an interventional clinical study during treatment with aflibercept,
* Patients with ocular pathologies who required surgery during the first 24 months of treatment with aflibercept (eg advanced glaucoma or cataracts).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT04891835
Study Brief:
Protocol Section:
NCT04891835